Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

AbbVie’s Strategic Defense: Skyrizi Maintains Dominance Against J&J’s New Rival

30/04/2026 Published by ViNe

Three years after navigating the Humira patent cliff, AbbVie CEO Robert Michael declares the company's position is "stronger than ever."... Read more

Tags: #Global Trends

A 6,000 billion VND M&A deal: Top 25 Chinese pharmaceutical group takes control of Imexpharm

30/04/2026 Published by ViNe

The Vietnamese pharmaceutical sector has witnessed a major ownership transition at Imexpharm Pharmaceutical JSC (HoSE: IMP). Following a successful public... Read more

Category: Uncategorized

Tags: #M&A

Healthcare administrative reform: Decentralization and simplification of business conditions from July 2026

30/04/2026 Published by ViNe

The Government has officially issued Resolution No. 21/2026/NQ-CP, marking a significant shift in healthcare administration. This resolution focuses on streamlining... Read more

Category: Uncategorized

Tags: #Vietnam

Drowning – Acute Oxygen Deprivation Due To Water Asphyxiation And Rapid Risk Of Brain Injury

29/04/2026 Published by ViNe

Drowning is one of the most dangerous emergencies—but also one of the most misunderstood. it’s often silent, quick, and easy... Read more

Category: Uncategorized

Tags: #Corporate Wellness

Bridging the manager readiness gap for 2026 strategy

29/04/2026 Published by ViNe

The success of any organizational strategy is determined at the managerial level, where abstract goals are translated into daily operations.... Read more

Category: Uncategorized

Tags: #Human Resources

Boehringer reports 16.6% weight loss in phase 3 trial for survodutide

29/04/2026 Published by ViNe

Boehringer Ingelheim has released topline data from its Synchronize-1 phase 3 study, revealing that its drug candidate survodutide led to... Read more

Category: Uncategorized

Tags: #Global Trends

Eli Lilly enters $2.2 billion genomic alliance with Bezos-backed Profluent

29/04/2026 Published by ViNe

Eli Lilly has forged a major partnership with Profluent to develop advanced gene-editing tools using artificial intelligence, aiming to address... Read more

Category: Uncategorized

Tags: #Global Trends

Merck and Remepy form alliance to pioneer hybrid drug development

29/04/2026 Published by ViNe

Merck KGaA has entered into a collaborative agreement with Remepy to develop integrated "hybrid drugs" that merge pharmacological treatments with... Read more

Category: Uncategorized

Tags: #Global Trends